Gonyer David A 4
4 · Evoke Pharma Inc · Filed Feb 4, 2022
Insider Transaction Report
Form 4
Evoke Pharma IncEVOK
Gonyer David A
DirectorPresident and CEO
Transactions
- Award
Stock Option (Right to Buy)
2022-02-02+175,000→ 175,000 totalExercise: $0.55Exp: 2032-02-01→ Common Stock (175,000 underlying)
Footnotes (1)
- [F1]The option shall vest at the rate of 1/48th of the original number of shares on each monthly anniversary of January 1, 2022, subject to the reporting person's continuous service to the issuer on each such vesting date.